The firm says its existing cash will fund it through 2025. The post Compass Pathways Research, Clinical Trials Buoyed by Influx of New Funds appeared first...
Clinical-stage psychedelics biotech Mind Medicine (MindMed) (NASDAQ: MNMD) has shared its financial outcomes for the third quarter ended September 30,...
Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and...
"Only luck prevented it from becoming a mass disaster," said a lawyer from the firm representing the Alaska Airlines plaintiffs.
The company said it has enough cash to continue operations into 2026. The post MindMed Advances Medical LSD Studies for Anxiety, Autism with $177M in the...
On this episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Christi Myers, the author of The Founder and CEO of Flow Integrative....
Plane pilot Jonathan J. Dunn has been indicted over an August 2022 incident.
This morning we received interim results on Cybin’s Phase 2 trial using its CYB003 psilocybin compound for depression. And they did not disappoint. The...
Alabama Psychedelic Reform is Lagging Alabama is a historically conservative state with little participation in drug reform efforts. As a result, most...
As the psychedelic movement transforms and develops into a new entity, there is bound to be internal conflict and opposition. The fight to include indigenous...